Evidence map›Paper›PMID 33557647›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2021

New 3-

Zi Han Loh, Huey Chong Kwong, Kok Wai Lam, Soek Sin Teh, Gwendoline Cheng Lian Ee, Ching Kheng Quah, Anthony Siong Hock Ho, Siau Hui Mah

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  5. Review
  6. An overview of structure-based activity outcomes of pyran derivatives against Alzheimer's disease.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  7. Multi-Targeting Neuroprotective Effects ofInternational journal of molecular sciences · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zi Han LohSchool of Biosciences, Taylor's University, Lakeside Campus, Subang Jaya, Malaysia.
Huey Chong KwongSchool of Chemical Sciences, Universiti Sains Malaysia, George Town, Malaysia.
Kok Wai LamDrug and Herbal Research Centre, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Soek Sin TehEnergy and Environment Unit, Engineering and Processing Division, Malaysian Palm Oil Board, Bandar Baru Bangi, Malaysia.
Gwendoline Cheng Lian EeDepartment of Chemistry, Faculty of Science, University Putra Malaysia, Serdang, Malaysia.
Ching Kheng QuahX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, George Town, Malaysia.
Anthony Siong Hock HoSchool of Biosciences, Taylor's University, Lakeside Campus, Subang Jaya, Malaysia.
Siau Hui MahSchool of Biosciences, Taylor's University, Lakeside Campus, Subang Jaya, Malaysia.ORCID https://orcid.org/0000-0003-0370-4866

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new series of 3-

Indexed as

AcetylcholinesteraseAnimalsButyrylcholinesteraseCholinesterase InhibitorsCrystallography, X-RayDose-Response Relationship, DrugElectrophorusHorsesModels, MolecularMolecular StructureStructure-Activity RelationshipXanthonesAcetylcholinesteraseButyrylcholinesteraseCholinesterase InhibitorsxanthoneXanthonesAlzheimer’s diseaseenzyme kinetic studymolecular dockingstructure–activity relationship studysynthesis

Identifiers

PMID33557647
PMCPMC8759733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.